Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shenyang Xingqi Pharmaceutical (300573 CH)
Watchlist
19
Analysis
Health Care
•
China
Shenyang Xingqi Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, produces, and distributes ophthalmic medicines including anti-bacterial products, allergy medicines, cataract preventions, and glaucoma treatments.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Dbg Technology
•
17 Jul 2024 17:58
Quiddity Leaderboard ChiNext & ChiNext 50 Dec 24: Multiple Ranking Changes; Double-Impacts for Some
There could be US$474mn one-way flows collectively for the ChiNext and ChiNext 50 December 2024 index rebal events. We see 9 changes for ChiNext...
Janaghan Jeyakumar, CFA
Follow
248 Views
Share
bullish
•
Gambol Pet Group
•
24 Jun 2024 18:14
Quiddity Leaderboard ChiNext & ChiNext 50 Dec 24: Expected ADDs Could Outperform Expected DELs
We estimate one-way turnover to be US$343mn for the ChiNext index rebalance and US$130mn for the ChiNext 50 index rebalance in December 2024.
Janaghan Jeyakumar, CFA
Follow
271 Views
Share
bullish
•
Victory Giant Technology -A
•
03 Jun 2024 14:07
ChiNext/ChiNext 50 Index Rebalance: US$1bn Round-Trip Trade
There are 7 changes for the Chinext and 5 changes for the Chinext50. Beijing Ultrapower and Victory Giant are surprise adds for both indices. The...
Brian Freitas
Follow
350 Views
Share
bullish
•
CSPC Innovation Pharmaceutical-A
•
06 May 2024 20:23
Quiddity Leaderboard ChiNext & ChiNext 50 Jun 24: Bull-Bear Hot Streak Continues; Some Surprises
The Bullish Names have outperformed the Bearish Names by +17.7% since I published my last ChiNext insight on 10th April 2024.
Janaghan Jeyakumar, CFA
Follow
268 Views
Share
bullish
•
CSPC Innovation Pharmaceutical-A
•
10 Apr 2024 17:39
Quiddity Leaderboard ChiNext & ChiNext 50 Jun 24: Bullish Names Outperform Bearish Names Again
The Bullish Names have outperformed the Bearish Names in successive insights. There were 5.75% and 4.18% outperformances in the periods between Mid...
Janaghan Jeyakumar, CFA
Follow
441 Views
Share
Previous
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x